Digital-Healthcare
1
5M
1
1
- Areas of investment
Summary
The main department of described Corporate Investor is located in the Leeds. The company was established in Europe in United Kingdom.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Digital-Healthcare, startups are often financed by Quest for Growth, Gemma Frisius Fund. The meaningful sponsors for the fund in investment in the same round are Gemma Frisius Fund.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The top amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2014.
Among the various public portfolio startups of the fund, we may underline Cartagenia Among the most popular fund investment industries, there are Genetics, Software. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Belgium.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Genetics (1)
- Investments by region
-
- Belgium (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
Data1 Finished!
Buy stuff!
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.